Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Statement of Comprehensive Income

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Gilead Sciences Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income
Net gain (loss) on foreign currency translation
Net gain (loss) on available-for-sale debt securities
Net gain (loss) on cash flow hedges
Other comprehensive income (loss), net
Comprehensive income (loss), net
Comprehensive loss attributable to noncontrolling interest, net
Comprehensive income (loss) attributable to Gilead, net

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Comprehensive income item Description The company
Net income attributable to Gilead The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Gilead Sciences Inc. net income attributable to Gilead increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
Comprehensive income (loss) attributable to Gilead, net Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Gilead Sciences Inc. comprehensive income (loss) attributable to Gilead, net increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.